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Background and Objective: Given the rising tendency of using insects as food, research 
regarding the food safety issues and health implications of edible insects are necessary. Insects 
have an external skeleton that is mainly composed of chitin- a nontoxic, fiber-like 
polysaccharide. Chitin and its derivative compounds can take part in maintaining healthy gut 
microbiota, by promoting or inhibiting the growth of several gut bacteria depending on the 
chitinous substrate. Healthy composition of gut microbiota can prevent intestinal disease 
states and food digestion problems. The aim of the study is to characterize the impact of chitin 
and chitooligosaccharides on the growth of two gut bacteria Lactobacillus rhamnosus GG and 
Escherichia coli TG, to provide further understanding on possible outcomes of consuming 
insects. 
Materials and Methods: Micro plate wells were prepared with tryptone soy broth in 0.5 and 
0.1% wv-1 chitin concentrations and in 0.5, 0.1, and 0.05% wv-1 chitooligosaccharide 
concentrations. Bacteria were added and the growth parameters of Lactobacillus rhamnosus 
GG and Escherichia coli TG were obtained by measurement of optical density at 600 nm in 
37ºC. 
Results and Conclusion: Chitooligosaccharides enhanced the growth of Lactobacillus 
rhamnosus GG and inhibited the growth of Escherichia coli TG in the lowest tested 
concentration of 0.05% wv-1. Chitin completely inhibited the growth of both bacteria in the 
lowest tested concentration of 0.1% wv-1. Chitooligosaccharides appear promising as potential 
prebiotic compounds associated with insect food products. Chitin has a strong antibacterial 
effect on tested bacteria. However, the In vitro results should be verified in well-designed 
human studies. 
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Demand for food is expected to rise in the coming 
decades due to population growth. A promising solution to 
the challenges this presents is the use of insects as food and 
as animal feed. Insect farming can contribute to the 
Sustainable Development Goals set by the United Nations; 
when used in accordance with the principles of a circular 
economy, farmed insects can provide an environmentally 
sustainable alternative to current sources of animal protein 
[1,2]. 
Protein levels in edible insects are comparable to those 
in conventional livestock, and they are rich in polyun-
saturated fats and micronutrients [3,4]. Beyond their 
nutritional value, food insects may also provide unique 
functional benefits to human health. Particularly interesting 
is chitin, the fiber-like main compound of the external 
skeleton of insects that is naturally present in variable 
amounts in commonly consumed insect species. Meal-
worms, as an example of insect species with the potential 
for being farmed on a commercial scale, have been 
estimated to contain between 4% and 8% chitin on a dry 
weight basis [5]. 
Recent studies have modified the industrial processing 
of food insects, with the aim of developing food 
ingredients that are more palatable for consumers than 
visually identifiable insects [6,7]. The process known as 
fractionation, besides extracting protein and fats, can yield 
a fraction rich in chitin [6]. These chitin fractions have the 
potential to serve as functional food additives or as 
ingredients in variety of applications. 
Chitin is a polysaccharide composed of β (1→4)-linked 
N-acetyl-2-amino-2-deoxy-glucose units (GlcNAc) [8]. 
Chitin is water insoluble, but humans have digestive 
enzymes in their gastrointestinal (GI) tract that are capable 
of degrading chitin to some extent [9]. Chitinolytic 
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enzymes breakdown the glycosidic bonds between 
GlcNAc units and degrade chitin into its derivatives 
chitosan, chitooligosaccharides (COS), and chitooligomers 
[10-12]. Lysozyme is known to catalyze the deacetylation 
of 2-acetamino groups and the parting of glycoside bonds 
between GlcNAc units of chitin, thus producing chitosan, a 
partially deacetylated byproduct of chitin degradation 
[13,14]. Acidic mammalian chitinase (AMCase) can digest 
chitin into N-acetyl-COS compounds, which are COS 
compounds that consist only from few GlcNAc units 
[9,15,16]. Thus, they have low molecular weight (MW) and 
are easily absorbed into blood circulation from the GI tract. 
When consumed in insect-derived food or obtained 
through chitin degradation, chitin and its derivatives COS 
and chitosan are functional fibers that can lower LDL 
cholesterol levels in blood [17-19]. Chitosan and COS 
particles are non-allergenic bioactive nutrients and are 
reported to have immune enhancing, antioxidative, anti-
inflammatory and antitumor capabilities [20-25]. If chitin 
is degraded into chitosan and COS particles with low 
enough MW, they can be absorbed into the bloodstream and 
transferred to all organs and tissues, where they can then 
have the aforementioned beneficial effects [26,27]. 
Chitin and its derivatives may also help to maintain a 
balanced and healthy gut microbiota. The composition of 
the human gut microbiota has an effect on many intestinal 
disease states and digestion disorders [28,29]. A balanced 
composition keeps the amounts of potentially harmful 
bacteria low and reduces the risk of intestinal diseases 
[30,31]. Generally, the health-promoting effects of 
beneficial gut bacteria are attributed to their competitive 
exclusion of non-beneficial bacteria. 
Chitin and its derivatives have been found to reduce the 
growth of some of the more harmful bacteria, such as 
Escherichia (E.) coli, Vibrio (V.) cholerae, Shigella (S.) 
dysenteriae, and Salmonella (S.) typhimurium [32-34]. By 
inhibiting the growth of non-beneficial bacteria, chitin and 
its derivatives enable the proliferation of beneficial gut 
bacteria species of the Lactobacillus and Bifidobacteria 
genera [35]. COSs have also been found to have direct 
prebiotic effects on Bifidobacteria and Lactobacillus 
species [12,36]. These effects are dependent on the MW and 
on the degree of acetylation of the COS [36-38]. COS 
molecules can act as decoy molecules, preventing the 
adhesion of E. coli, or other more harmful bacteria, to the 
epithelium of the GI tract [39,40]. 
Although chitin and chitosan have been studied in 
depth for purposes of extraction, bioengineering, and 
healthcare applications, few studies have focused on the 
actual consumption of chitin and its nutrient effects in the 
context of edible insects. In the present study, we 
hypothesize that insect foods form a novel means can be 
used to create and maintain a healthy gut microbiota. We 
further hypothesize that COS obtained from insect-derived 
food through chitin degradation functions as a new 
prebiotic by reducing the growth of harmful bacteria and 
promoting the growth of probiotic bacteria, thus making 
consumption of insects beneficial for human health. 
Therefore, we examined the In vitro effects of chitin and 
chitosan on the growth of Lactobacillus (L.) rhamnosus 
GG, a well-known probiotic microorganism, and on E. 
coli, a bacterium that is not harmful in small numbers but 
is potentially an opportunistic pathogen especially when 
abundant in the gut. 
2. Materials and Methods 
2.1 Bacterial cultivations 
L. rhamnosus GG (LGG) (ATCC 53103) and E. coli 
TG were chosen for the present study because E. coli is 
normally present in the GI tract and LGG, also normally 
present in the GI tract, is widely used in Finland as a food 
probiotic. The bacteria were cultivated in tryptone-soy-
agar (TSA) plates using Tryptone Soy Broth (TSB) 
(CM0129, Oxoid Microbiology Products, Thermo Fischer 
Scientific Inc. Massachusetts, USA) and agar (MC006, 
Lab M, A Neogen Company, Lancashire, UK) at 37ºC. 
The E. coli grew colonies suitable for extraction in 22 to 
26 hours, whereas for the LGG the same process took 4 to 
6 days. Cultivation was continued throughout the 
experiment by extracting colonies to new TSA plates. 
2.2 Preparation of chitin and COS solutions and bacter-
ial stock solution 
COS stock solution was prepared by mixing COS 
powder with a degree of deacetylation (DD)≥90% and MW 
≤1.5 kDa (237589, Bonding Chemical, Texas, USA) into 
diH2O to a concentration of 50 g l-1. As chitin is insoluble 
in water, a stock solution was prepared by dissolving chitin 
powder (C7170-100G, Sigma-Aldrich Corporation, 
Missouri, USA) into a 50% wv-1 NaOH solution (30620 
1KG R, Sigma-Aldrich, Missouri USA) at a concentration 
of 50 g l-1. Experiments on NaOH’s chitin deacetylating 
effects were not included in this study, but knowing that 
NaOH might affect in such way, dilutions were prepared 
and used immediately after preparation of chitin’s stock 
solutions. 
The chitin and COS stock solutions were further diluted 
to concentrations of 5 g l-1 and 1 g l-1 for the chitin, and to 
5 g l-1, 1 g l-1 and 0.5 g l-1 for the COS. Corresponding 
control solutions for the chitin and COS solutions were 
prepared. A negative blank control of TSB broth without 
chitin or COS solutions and bacteria was also employed. A 
positive control with bacteria and TSB but without chitin 
or COS solutions was also employed (Table 1).  
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Negative control 10 - 9.7 0.3 - 
Positive control 10 - 9.504 0.3 0.1 
Chitin 0.5% wv-1 10 1 8.64 0.3 0.1 
Chitin 0.1% wv-1 10 0.2 9.408 0.3 0.1 
Chitin control 0.5% wv-1 10 1 8.7 0.3 - 
Chitin control 0.1% wv-1 10 0.2 9.5 0.3 - 
Chitooligosaccharide 0.5% wv-1 10 1 8.64 0.3 0.1 
Chitooligosaccharide 0.1% wv-1 10 0.2 9.408 0.3 0.1 
Chitooligosaccharide 0.05% wv-1 10 0.1 9.504 0.3 0.1 
Chitooligosaccharide control 0.5% wv-1 10 1 8.7 0.3 - 
Chitooligosaccharide control 0.1% wv-1 10 0.2 9.5 0.3 - 
Chitooligosaccharide control 0.05% wv-1 10 0.1 9.6 0.3 - 
 
TSB powder (0.3 g) was added to all the chitin and 
COS solutions and their controls. All the solutions and 
controls were sterilized in an autoclave and stored 
overnight at 4ºC. 
For each run of 96-well plates, a bacterial stock 
solution was prepared containing the same amounts of E. 
coli or LGG. Bacterial stock solution was prepared by 
extracting colonies from the TSA plates to cuvettes 
containing 1 ml of phosphate-buffered saline (PBS) (NaCl 
8.5 g l-1, K2HPO4 1.21 g l-1, KH2PO4 0.34 g l-1, with diH2O 
added to a volume of 1 l, pH=7.2). The bacterial growth 
density was adjusted to match the Mac Farland standard, 
3×108 bacteria per ml at optical density A=0.250 by 
measuring wavelength at 600 nm with a spectrophotometer 
(UV/VIS UV1601 Spectrophotometer, Shimadzu Corpo-
ration, Kyoto, Japan) and then adding bacteria to match the 
desired optical density. A tenfold dilution was made into 
PBS for the bacterial stock solution and 100 ml of the 
desired bacterial stock solution was added to the positive 
controls and to the chitin and COS solutions. 
2.3 Measuring the optical density of cultivations 
The 96-well plates were prepared by pipetting 300 ml 
of the chitin and COS solutions and their respective 
controls into their appointed wells. Each plate contained a 
total of 12 different types of well and eight repeats of each 
type. Three replicates were made for the E. coli plates and 
four for the LGG plates. 
Bacterial growth was measured as an increase in optical 
density (OD) in the wells of a 96-well plate in a plate 
reader (Synergy H1, Hybrid Multi-Mode Reader, BioTek 
Instruments Inc, Vermont, USA). The plates were 
maintained at a constant temperature of 37ºC, and 
measurements of OD were taken every 30 minutes for 20 
to 26 hours at a wavelength of 600 nm. A similar method 
for measuring the turbidity of cultures was used by 
Benhabiles et al. [33]. 
Gen5 data analysis software (Gen5 Software, software 
version 3.0, BioTek Instruments Inc, Vermont, USA) was 
used to record the results. Data values from the control 
wells were substituted from the corresponding values of 
the chitin and COS wells for purposes of background 
correction. 
2.4 Statistical analysis 
IBM SPSS software (IBM SPSS statistics 24.0 
software, IBM Corp., Armonk, NY, USA) was used for 
statistical analysis. The Shapiro-Wilk test was applied to 
check the data for normal distribution. Differences were 
considered significant at p≤0.05. One-way ANOVA was 
employed for comparison of normally distributed data. 
Because of unequally distributed variances, the Games-
Howell nonparametric post-hoc test was applied to 
compare the differences between the groups. For the 
comparison of non-normally distributed data, the Kruskal-
Wallis and Mann-Whitney U tests were employed. 
3. Results and Discussion 
3.1 The effects of chitin and COS on the growth of E. 
coli TG 
As shown in Figure 1, COS reduced the growth of E. 
coli, whereas chitin inhibited its growth. In all COS 
concentrations the total growth and the growth rate of E. 
coli were reduced compared to the untreated control. There 
were no significant differences between the 0.5% wv-1 and 
0.1% wv-1 concentrations of chitin in respect of their ability 
to prevent E. coli growth. No growth was observed in E. 
coli in the presence of chitin. 
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Figure 1. The effects of chitin and chitooligosaccharide on the growth of Escherichia coli TG  
Rising values in y-axis’s optical density signify for bacteria population’s growth. The figure illustrates the inhibitory effects of chitin and 
chitooligosaccharide concentrations (% wv-1) on the growth of Escherichia coli. Control is an untreated group without chitin and chitooligosaccharide. 
 
The inhibitory effect of COS was more efficient at 
higher concentrations (Table 2). The growth rate was 
fastest in the untreated E. coli control. E. coli’s growth rate 
was slowed with rising COS concentrations. At COS 
concentrations of 0.5% wv-1 the growth of E. coli was 
approximately 63% slower than in the untreated control 
group. The total population growth of E. coli was also 
lower in higher COS concentrations.  
Statistically significant differences were found between 
the untreated control and the COS concentrations in 
respect of maximum growth rate and total population 
growth (Table 2). Statistically significant differences were 
also found between COS 0.5% wv-1 and COS 0.05% wv-1 
in respect to inhibiting the growth rate of E. coli: COS 
0.5% wv-1 was more efficient than COS 0.05% wv-1. 
Whereas in the present study COS with 1.5 kDa 
inhibited E. coli’s growth in 0.05% wv-1 the lowest 
concentration tested, Fernandes et al. reported that COS 
with MW lower than 5 kDa and 3 kDa inhibited E. coli’s 
growth in a concentration of 0.25% wv-1 [32]. Jeon et al. 
observed inhibitory effects for E. coli in COS conc-
entrations between 0.06% wv-1 and 0.12% wv-1, which is 
the lowest reported minimum inhibitory concentration with 
confirmed MW‘s of COS particles ranging from 24 kDa to 
7 kDa [41]. Though Benhabiles et al. reported lower 
minimum inhibitory concentration of COS on E. coli to be 
0.003% wv-1, they did not describe the actual MW of COS 
used. Based on their reporting the MW was presumably <12 




Table 2. The effects of chitooligosaccharide on the growth of Escherichia coli TG 
Escherichia coli TG Latency (h) Max growth rate (OD h-1) Total growth (OD) 
Control 4.935 (4.70-5.29) 0.203 (0.20-0.21)a 1.032 (0.96-1.06)a 
Chitooligosaccharide 0.05% wv-1 4.915 (4.81-5.01) 0.178 (0.16-0.19)b 0.869 (0.83-0.95)b 
Chitooligosaccharide 0.1% wv-1 4.789 (4.72-5.04) 0.161 (0.14-0.17)b,c 0.907 (0.66-0.92)b 
Chitooligosaccharide 0.5% wv-1 4.639 (4.51-4.80) 0.127 (0.12-0.15)c 0.820 (0.66-0.86)b 
Results are reported in median values with range in parenthesis from min to max. Latency is reported in hours and the total amount of population’s growth is 
reported in optical density (OD) (i.e. Absorbance at 600 nm). The maximum rate of growth is reported as OD versus the culture time (h). Different letters in 
the same columns indicate the statistically significant difference in a confidence level of p≤0.05. 
 































_______________________________Chitin & chitooligosaccharide_______________________________________________________________________ 
 
Appl Food Biotechnol, Vol. 5, No. 3 (2018)_______________________________________________________________________________________167  
 
In the current study chitin inhibited the growth of E. 
coli growth completely in 0.1% wv-1 concentration in 
contrast to the results of Raut et al. who found that 0.1% 
wv-1 chitin concentration only decreased E. coli’s growth 
by 18% [34]. Benhabiles et al. reported minimum inhibit-
ory concentrations of chitin for E. coli at 0.01% wv-1. 
These variations may be attributed to using chitins of 
different MW and DD or different bacterial strains used 
[33]. Chitin’s effects on bacteria should be also studied in 
conditions that don’t require it to be soluble, thus not 
including NaOH for solvent. In this experiment NaOH 
effect on bacteria was expected to be minimal since it was 
diluted in ratios of 1:10 and 1:50 for the desired chitin 
concentrations. 
3.2 The effects of chitin and COS on the growth of 
Lactobacillus rhamnosus GG 
As shown in Figure 2, COS promoted the growth of 
LGG, whereas chitin prevented its growth entirely. For 
each of the COS concentrations, the total growth and the 
growth rate of the LGG exceeded that of the untreated 
controls. There were no significant differences between the 
0.5% wv-1 and 0.1% wv-1 concentrations of chitin in respect 
to their ability to prevent LGG growth. No growth was 
observed in LGG in the presence of chitin. 
Each of the COS concentrations showed a statistically 
significant difference in the maximum growth rate 
compared to the control group (Table 3). The growth 
promoting effect of COS was found to be greater at higher 
COS concentrations. The growth rate was slowest in the 
control and almost twice as fast in the highest COS 
concentration. Furthermore, the amount of total population 
growth was greater at higher COS concentrations. 
Although there were no statistically significant differences 
among the COS and the controls in respect of latency or 
total amount of growth, the latency time for COS 0.05% 
wv-1  was lower than for the control group. 
 
 
Table 3. The effects of chitooligosaccharide on the growth of Lactobacillus rhamnosus GG 
Lactobacillus rhamnosus GG Latency (h) Max growth rate (OD h-1) Total growth (OD) 
Control 18.069 (16.18-19.15) 0.049 (0.03-0.06)a 0.470 (0.33-0.61) 
Chitooligosaccharide 0.05% wv-1 17.655 (16.25-20.01) 0.073 (0.06-0.09)a,b 0.599 (0.44-0.72) 
Chitooligosaccharide 0.1% wv-1  18.140 (16.23-18.59) 0.082 (0.07-0.09)b 0.667 (0.53-0.74) 
Chitooligosaccharide 0.5% wv-1  18.403 (16.14-19.66) 0.087 (0.08-0.10)b 0.633 (0.49-0.71) 
Results are reported in median values with range in parenthesis from min to max. Latency is reported in hours and the total amount of population’s 
growth is reported in optical density (OD) (i.e. absorbance at 600 nm). The maximum rate of growth is reported as OD versus the culture time (h). 





Figure 2. The effects of chitin and chitooligosaccharide on the growth of Lactobacillus rhamnosus GG 
Rising values in y-axis’s optical density signify for bacteria population’s growth. The figure illustrates the inhibitory effects of chitin and the growth 
promoting effects of chitooligosaccharide concentrations (% wv-1) on the growth of Lactobacillus. Control is an untreated group without chitin and 
chitooligosaccharide.
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Contrary to results in the current study, Jeon et al. 
reported that COS to inhibited the growth of Lactobacilli in 
concentrations of 0.1% wv-1 and 0.03% wv-1 [41]. They 
also stated that COS was more efficient in inhibiting the 
growth of non-beneficial bacteria than the beneficial ones 
except for Lactobacilli. This contradiction may be 
accounted for different MW’s of the COS’s used; 24 kDa 
and 7 kDa compared to 1.5 kDa used in the present 
experiment. Also, they used different lactobacilli, e.g. L. 
casei, L. bulgaricus, and L. fermentum. The effect on 
different strains of Lactobacillus should be verified on 
COSs with similar characteristics. 
3.3 Impact of receiving chitin and COS from consum-
ing insects 
According to the results of the current study, In vitro 
COS with MW ≤1.5 kDa and DD ≥ 90% promotes the 
growth of LGG and reduces the growth of E. coli in a 
dose-dependent manner, indicating that the COS tested 
here has the potential for prebiotic activity In vivo. More 
competent effects of COS’ promotion of LGG’s growth 
and inhibition of E. coli could be expected from insect 
foods that contain higher amounts of COS or from efficient 
chitin digestion by AMCase in the GI tract, which would 
result in higher yields of COS. 
The fact that AMCase produces N-acetyl-COS from 
chitin In vivo after the consumption of insects is very 
promising in respect to obtaining beneficial effects for gut 
microbiota and for human health. According to Mateos-
Aparicio, et al. COSs with many acetylated residues are 
more efficient in promoting the growth of beneficial 
Lactobacillus than deacetylated COSs [36]. However, 
regarding the inhibition of the growth of non-beneficial 
bacteria, Benhabiles et al. reported that the degree of 
acetylation of COS is inconsequential [33]. The N-acetyl-
COS compound, a direct result of AMCase breakdown of 
chitin, is thus efficient in both promoting the beneficial 
bacteria and inhibiting the non-beneficial bacteria. 
Whether N-acetyl-COS would be further deacetylated, it 
would still promote the growth of LGG in accordance to 
the findings of this study. 
The inhibitory effects on E. coli growth have been 
hypothesized by Zheng and Zhu and tested by Je and Kim 
to be resulting from chitin’s and COS’s ability to disrupt 
bacterial cell membranes [37,42]. By inhibiting the growth 
of E. coli, chitin reduces the levels of harmful bacteria, but 
it also prevented the growth of favorable LGG in this 
study. While chitin has an inhibitory effect to beneficial 
LGG growth, it may still contribute to gut health as 
functional fiber. Chitin’s strong antibacterial effect could 
be utilized for commercial purposes, such as natural 
preservatives in the food industry to improve the shelf-life 
of foods [43-45]. 
Chitin and COS demonstrated similar outcomes on 
tested bacteria independent from each other. In future 
studies, simultaneous exposure to chitin and COS in 
different ratios should be carried out as both substances 
will be present in the GI tract following an insect meal. As 
no research on the inhibitory effects of chitin on 
Lactobacillus was found by the authors, these factors 
should be further elucidated. 
From varying results in antimicrobial studies stated 
above, it can be concluded that the structure (MW and DD) 
of chitin and its byproducts contribute to the antiprolif-
erative or proliferative effects of the molecules. Reporting 
of the results of antimicrobial activities of chitin and its 
degradation products In vitro should always include exact 
MW data. In vivo studies of effects of chitin from insect 
foods should focus on studying the functionality of chitin 
since its structure can vary greatly in insects themselves. 
Also, chitin will be degraded by digestive enzymes, 
making it less significant to measure exact characteristics 
of the chitin that is being consumed. The ratio of different 
chitin and its derivative chitosan and COS compounds 
present in the GI tract after eating insects is of importance 
when assessing the functional properties of insect foods on 
the gut microbiota and human health. These effects should 
be demonstrated In vivo. 
The effects of chitin from insect consumption depend 
on how well chitin is being degraded by digestive 
enzymes, the amount of derivative compounds formed in 
the process, how long or short chained the derivative 
molecules are and what kind of bioactive side chains they 
contain. To obtain all the positive effects of chitin and its 
byproducts, both lysozyme and AMCase are needed for 
efficient chitin breakdown. Presumably the health benefits 
of the consumed insect foods are fewer in the people 
whose AMCase expression is insufficient for efficient 
chitin degradation, compared to those with abundant 
AMCase expression [9]. Understanding the function and 
efficiency of AMCase, lysozyme, gut bacteria and other 
possible factors in the chitin digestion is essential to gain 
knowledge on the amounts and types of COS and chitosan 
produce. To fully understand the comprehensive effects of 
chitin and its derivatives in humans, further research 
should be aimed at human intervention studies using insect 
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4. Conclusion 
In the present study COS ameliorated the growth of 
LGG and inhibited the growth of E. coli TG In vitro, 
showing the potential of similar prebiotic-like effects to be 
expected In vivo. Chitin completely inhibited the growth of 
both tested bacteria but due to its strong antimicrobial 
effect, chitin could serve as a natural food preservative. 
When consumed in insect foods, chitin and its derivatives 
which cannot be absorbed may function as fiber. Chitin 
can add to the value of insects as food items with its 
functional fiber like characteristics and the gut microbiota 
enhancing effects of its digested state degradation 
products. 
Chitin’s, chitosan’s and COSs functionality and effects 
on gut microbiota and health are determined by their MW 
and DD. Chitin’s characteristics in the actual insect and 
thus in the insect food products can vary greatly. Because 
of this, the reporting of In vitro findings on antimicrobial 
effects should be standardized to include information on 
the MW and DD. 
For health benefits, chitin must be digested by AMCase 
and lysozyme into COS and chitosan in the GI tract. 
Otherwise, COS and chitosan must be available in suffi-
cient amounts from the insect food itself. Enzymatic 
degradation of chitosan in GI tract results on a wide range 
of different chitin byproducts such as chitosans and COS’s. 
Therefore, In vivo studies should focus on the complex 
matrices of chitin’s and its byproducts and their functions 
and the ratios in GI tract following an insect meal. 
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 اشرشیا کلی تی جیو  الکتوباسیلوس رامنوس جی جیبر رشد  کیتین و کیتواولیگوساکارید اثر
 در شرایط درون تنی
 پو سامینن، کارلوس گومز گالگو، جاکو کورپال، س*اوتو سلنیوس
 .تورکو، فنالند FI-40002 آیتینن پیت کاتو، دانشکده پزشکی، دانشگاه تورکو،انجمن غذاهای فراسودمند، 
 تاریخچه مقاله
 4002 فوریه 40دریافت 
 4002 می 00   داوری
 4002می  42  پذیرش
 چکیده 
 استفاده از حشرات به عنوان غذا، تحقیق درباره مسائل مربوط به ایمنیی و  با توجه به گرایش رو به رشدسابقه و هدف: 
ساکاریدی فیبر مانند از کیتین، پلی باشد. اسکلت خارجی حشرات عمدتاًپیامدهای سالمتی حشرات خوراکی ضروری می
های اختصاصی توانند در حفظ سالمت ریزاندامگانتشکیل شده است. کیتین و ترکیبات مشتق شده از آن می و غیرسمی
نقیش داشیته باشیند. ترکیبیات سیال   بسته به ماده اولیه کیتینی رودههای با افزایش یا مهار رشد برخی از باکتری روده
ند. هدف از مطالعیه ند از بیماری روده و مشکالت هض  مواد غذایی پیشگیری کنتوانهای اختصاصی روده میریزاندامگان
اشرشییا و  الکتوباسیلوس رامنوس جی جیی  ایساکاریدها بر رشد دو باکتری رودهمشخص کردن اثر کیتین و کیتواولیگو
 باشد.منظور درک بیشتر در خصوص پیامد احتمالی مصرف حشرات می به کلی تی جی
و  wv0/0 %-1 و 5/0هیای های میکروپلیت با تریپتیون سیوی بیراا حیاوی کیتیین در غلظیت چاهکها: مواد و روش
 گیریاندازهها اضافه و رشد داده شدند. با آماده شدند. باکتری wv05/0 %-1 و 0/0، 5/0های کیتواولیگوساکارید در غلظت
اشرشییا و  الکتوباسیلوس رامنیوس جیی جیی  درجه سلسیوس میزان 73نانومتر در درجه حرارت  200چگالی نوری در 
 به دست آمد. تی جیکالی
جیی الکتوباسییلوس رامنیوس ( رشد wv05/0 %-1کیتوزواولیگوساکاریدها در کمترین غلظت ) گیری:ها و نتیجهیافته
رشید هیر دو  (wv0/0 %-1کیتیین در کمتیرین غلظیت )  ا مهار کردند.ر اشرشیا کلی تی جی را افزایش دادند و رشد جی
موجیود  1یارعنوان ترکیبات بالقوه کمک زیست رسد کیتواولیگوساکاریدها بهطور کامل مهار کرد. به نظر می باکتری را به
هیای میورد آزمیون دارد. ه باشند. کیتین اثر ضدباکتریایی بر بیاکتری در مواد غذایی حاوی حشرات آیندهای روشن داشت
 دست آمده در شرایط درون تنی نیز باید با مطالعات انسانی اصولی تایید شود. هرچند، نتایج به
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